Farbod Shojaei, DVM, MSc, PhD

CSO

Dr. Shojaei has extensive knowledge in molecular biology, cell biology and translational sciences in small molecule inhibitors and biologics in the biotechnology and pharmaceutical industries. With over 28 years of experience, he previously served as Director, Drug Development and Biology at Zentalis Pharmaceuticals and Sanford Burnham Prebys Medical Discovery Institute, focusing on translational sciences in oncology. Dr. Shojaei also served at Bionomics Biotechnology, Pfizer, and Genentech. He has provided significant contributions to IND and NDA filings of several anti-cancer agents and is co-inventor of several US patent applications and authored multiple publications in professional journals. Dr. Shojaei received his DVM in Veterinary Medicine from Tehran University, MSc in Immunoglobulin Genetics from University of Guelph, and PhD in Immunology and Stem Cell Research at University of Western Ontario.